Biomx Inc Stock Today
| PHGE Stock | USD 0.71 0.11 18.33% |
Performance0 of 100
| Odds Of DistressOver 81
|
Biomx is trading at 0.71 as of the 2nd of December 2024, a 18.33 percent increase since the beginning of the trading day. The stock's lowest day price was 0.63. Biomx has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Biomx Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 2nd of December 2024. Click here to learn more.
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel. Biomx operates under Biotechnology classification in the United States and is traded on AMEX Exchange. The company has 18.18 M outstanding shares of which 23.03 K shares are at this time shorted by private and institutional investors with about 0.74 trading days to cover. More on Biomx Inc
Moving together with Biomx Stock
Moving against Biomx Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Biomx Stock Highlights
| Old Name | Biomx Inc |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Biomx Inc (PHGE) is traded on NYSE MKT Exchange in USA. It is located in 22 Einstein Street, Ness Ziona, Israel, 7414003 and employs 58 people. Biomx is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.91 M. Biomx Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 18.18 M outstanding shares of which 23.03 K shares are at this time shorted by private and institutional investors with about 0.74 trading days to cover.
Biomx Inc currently holds about 45.74 M in cash with (21.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.53, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Biomx Probability Of Bankruptcy
Ownership AllocationBiomx holds a total of 18.18 Million outstanding shares. Over half of Biomx's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biomx Ownership Details
Biomx Inc Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Biomx market risk premium is the additional return an investor will receive from holding Biomx long position in a well-diversified portfolio.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.73) | |||
| Total Risk Alpha | (1.48) | |||
| Treynor Ratio | (0.55) |
Biomx Stock Against Markets
Biomx Corporate Management
| Jonathan MBA | CEO Director | Profile | |
| Assaf Oron | Chief Officer | Profile | |
| Eran MD | Scientific Founder | Profile | |
| Merav Bassan | Chief Officer | Profile | |
| Avraham Gabay | Interim Officer | Profile | |
| Pr Sorek | Scientific Founder | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Biomx Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomx. If investors know Biomx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biomx Inc is measured differently than its book value, which is the value of Biomx that is recorded on the company's balance sheet. Investors also form their own opinion of Biomx's value that differs from its market value or its book value, called intrinsic value, which is Biomx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomx's market value can be influenced by many factors that don't directly affect Biomx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomx's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.